Cargando…
Nutraceuticals and Enteric Glial Cells
Until recently, glia were considered to be a structural support for neurons, however further investigations showed that glial cells are equally as important as neurons. Among many different types of glia, enteric glial cells (EGCs) found in the gastrointestinal tract, have been significantly underes...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234579/ https://www.ncbi.nlm.nih.gov/pubmed/34205534 http://dx.doi.org/10.3390/molecules26123762 |
_version_ | 1783714116483940352 |
---|---|
author | López-Gómez, Laura Szymaszkiewicz, Agata Zielińska, Marta Abalo, Raquel |
author_facet | López-Gómez, Laura Szymaszkiewicz, Agata Zielińska, Marta Abalo, Raquel |
author_sort | López-Gómez, Laura |
collection | PubMed |
description | Until recently, glia were considered to be a structural support for neurons, however further investigations showed that glial cells are equally as important as neurons. Among many different types of glia, enteric glial cells (EGCs) found in the gastrointestinal tract, have been significantly underestimated, but proved to play an essential role in neuroprotection, immune system modulation and many other functions. They are also said to be remarkably altered in different physiopathological conditions. A nutraceutical is defined as any food substance or part of a food that provides medical or health benefits, including prevention and treatment of the disease. Following the description of these interesting peripheral glial cells and highlighting their role in physiological and pathological changes, this article reviews all the studies on the effects of nutraceuticals as modulators of their functions. Currently there are only a few studies available concerning the effects of nutraceuticals on EGCs. Most of them evaluated molecules with antioxidant properties in systemic conditions, whereas only a few studies have been performed using models of gastrointestinal disorders. Despite the scarcity of studies on the topic, all agree that nutraceuticals have the potential to be an interesting alternative in the prevention and/or treatment of enteric gliopathies (of systemic or local etiology) and their associated gastrointestinal conditions. |
format | Online Article Text |
id | pubmed-8234579 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82345792021-06-27 Nutraceuticals and Enteric Glial Cells López-Gómez, Laura Szymaszkiewicz, Agata Zielińska, Marta Abalo, Raquel Molecules Review Until recently, glia were considered to be a structural support for neurons, however further investigations showed that glial cells are equally as important as neurons. Among many different types of glia, enteric glial cells (EGCs) found in the gastrointestinal tract, have been significantly underestimated, but proved to play an essential role in neuroprotection, immune system modulation and many other functions. They are also said to be remarkably altered in different physiopathological conditions. A nutraceutical is defined as any food substance or part of a food that provides medical or health benefits, including prevention and treatment of the disease. Following the description of these interesting peripheral glial cells and highlighting their role in physiological and pathological changes, this article reviews all the studies on the effects of nutraceuticals as modulators of their functions. Currently there are only a few studies available concerning the effects of nutraceuticals on EGCs. Most of them evaluated molecules with antioxidant properties in systemic conditions, whereas only a few studies have been performed using models of gastrointestinal disorders. Despite the scarcity of studies on the topic, all agree that nutraceuticals have the potential to be an interesting alternative in the prevention and/or treatment of enteric gliopathies (of systemic or local etiology) and their associated gastrointestinal conditions. MDPI 2021-06-21 /pmc/articles/PMC8234579/ /pubmed/34205534 http://dx.doi.org/10.3390/molecules26123762 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review López-Gómez, Laura Szymaszkiewicz, Agata Zielińska, Marta Abalo, Raquel Nutraceuticals and Enteric Glial Cells |
title | Nutraceuticals and Enteric Glial Cells |
title_full | Nutraceuticals and Enteric Glial Cells |
title_fullStr | Nutraceuticals and Enteric Glial Cells |
title_full_unstemmed | Nutraceuticals and Enteric Glial Cells |
title_short | Nutraceuticals and Enteric Glial Cells |
title_sort | nutraceuticals and enteric glial cells |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234579/ https://www.ncbi.nlm.nih.gov/pubmed/34205534 http://dx.doi.org/10.3390/molecules26123762 |
work_keys_str_mv | AT lopezgomezlaura nutraceuticalsandentericglialcells AT szymaszkiewiczagata nutraceuticalsandentericglialcells AT zielinskamarta nutraceuticalsandentericglialcells AT abaloraquel nutraceuticalsandentericglialcells |